Commonwealth Equity Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $56.2M | Sell |
975,574
-17,088
| -2% | -$981K | 0.07% | 281 |
|
|
2026
Q1 | $60.2M | Sell |
992,662
-252,846
| -20% | -$14.7M | 0.08% | 237 |
|
|
2025
Q4 | $67.2M | Buy |
1,245,508
+171,364
| +16% | +$8.24M | 0.09% | 219 |
|
|
2025
Q3 | $48.4M | Sell |
1,074,144
-96,839
| -8% | -$4.52M | 0.06% | 297 |
|
|
2025
Q2 | $54.2M | Sell |
1,170,983
-117,424
| -9% | -$5.76M | 0.07% | 273 |
|
|
2025
Q1 | $78.6M | Buy |
1,288,407
+13,959
| +1% | +$814K | 0.11% | 174 |
|
|
2024
Q4 | $72.1M | Buy |
1,274,448
+103,592
| +9% | +$5.79M | 0.11% | 180 |
|
|
2024
Q3 | $60.6M | Sell |
1,170,856
-31,898
| -3% | -$1.5M | 0.09% | 214 |
|
|
2024
Q2 | $50M | Buy |
1,202,754
+79,413
| +7% | +$3.55M | 0.08% | 231 |
|
|
2024
Q1 | $60.9M | Buy |
1,123,341
+16,582
| +1% | +$845K | 0.1% | 191 |
|
|
2023
Q4 | $56.8M | Sell |
1,106,759
-95,627
| -8% | -$5.02M | 0.1% | 186 |
|
|
2023
Q3 | $69.8M | Sell |
1,202,386
-44,144
| -4% | -$2.7M | 0.14% | 141 |
|
|
2023
Q2 | $79.7M | Buy |
1,246,530
+15,881
| +1% | +$1.06M | 0.16% | 125 |
|
|
2023
Q1 | $85.3M | Buy |
1,230,649
+57,046
| +5% | +$4.02M | 0.18% | 115 |
|
|
2022
Q4 | $84.4M | Buy |
1,173,603
+26,194
| +2% | +$1.98M | 0.2% | 104 |
|
|
2022
Q3 | $81.6M | Sell |
1,147,409
-6,278
| -0.5% | -$455K | 0.21% | 88 |
|
|
2022
Q2 | $88.8M | Sell |
1,153,687
-4,208
| -0.4% | -$320K | 0.23% | 86 |
|
|
2022
Q1 | $84.6M | Sell |
1,157,895
-15,310
| -1% | -$1.03M | 0.19% | 101 |
|
|
2021
Q4 | $73.1M | Sell |
1,173,205
-11,581
| -1% | -$679K | 0.16% | 127 |
|
|
2021
Q3 | $70.1M | Sell |
1,184,786
-10,255
| -0.9% | -$675K | 0.18% | 122 |
|
|
2021
Q2 | $79.9M | Buy |
1,195,041
+46,899
| +4% | +$3.06M | 0.2% | 96 |
|
|
2021
Q1 | $72.5M | Buy |
1,148,142
+54,089
| +5% | +$3.37M | 0.21% | 96 |
|
|
2020
Q4 | $67.9M | Sell |
1,094,053
-6,326
| -0.6% | -$389K | 0.2% | 105 |
|
|
2020
Q3 | $66.3M | Buy |
1,100,379
+63,654
| +6% | +$3.83M | 0.23% | 89 |
|
|
2020
Q2 | $61M | Buy |
1,036,725
+76,694
| +8% | +$4.59M | 0.23% | 89 |
|
|
2020
Q1 | $53.5M | Buy |
960,031
+13,073
| +1% | +$799K | 0.25% | 88 |
|
|
2019
Q4 | $60.8M | Buy |
946,958
+144,193
| +18% | +$8.26M | 0.23% | 87 |
|
|
2019
Q3 | $40.7M | Buy |
802,765
+8,537
| +1% | +$401K | 0.17% | 120 |
|
|
2019
Q2 | $36M | Buy |
794,228
+57,384
| +8% | +$2.67M | 0.16% | 134 |
|
|
2019
Q1 | $35.2M | Buy |
736,844
+62,915
| +9% | +$3.13M | 0.16% | 131 |
|
|
2018
Q4 | $35M | Buy |
673,929
+7,250
| +1% | +$390K | 0.19% | 115 |
|
|
2018
Q3 | $41.4M | Buy |
666,679
+2,532
| +0.4% | +$150K | 0.2% | 110 |
|
|
2018
Q2 | $36.8M | Sell |
664,147
-21,854
| -3% | -$1.18M | 0.19% | 115 |
|
|
2018
Q1 | $43.4M | Sell |
686,001
-19,285
| -3% | -$1.24M | 0.24% | 97 |
|
|
2017
Q4 | $43.2M | Sell |
705,286
-9,586
| -1% | -$600K | 0.24% | 95 |
|
|
2017
Q3 | $45.6M | Buy |
714,872
+13,279
| +2% | +$775K | 0.27% | 87 |
|
|
2017
Q2 | $39.1M | Buy |
701,593
+126
| +0% | +$6.86K | 0.25% | 90 |
|
|
2017
Q1 | $38.1M | Buy |
701,467
+54,081
| +8% | +$2.97M | 0.26% | 85 |
|
|
2016
Q4 | $37.8M | Buy |
647,386
+43,632
| +7% | +$2.39M | 0.28% | 75 |
|
|
2016
Q3 | $32.6M | Buy |
603,754
+67,579
| +13% | +$4.34M | 0.26% | 79 |
|
|
2016
Q2 | $39.4M | Sell |
536,175
-8,891
| -2% | -$628K | 0.33% | 66 |
|
|
2016
Q1 | $34.8M | Sell |
545,066
-15,900
| -3% | -$1M | 0.31% | 69 |
|
|
2015
Q4 | $38.6M | Buy |
560,966
+56,481
| +11% | +$3.73M | 0.37% | 57 |
|
|
2015
Q3 | $29.9M | Sell |
504,485
-18,207
| -3% | -$1.16M | 0.31% | 64 |
|
|
2015
Q2 | $34.8M | Buy |
522,692
+8,322
| +2% | +$548K | 0.35% | 55 |
|
|
2015
Q1 | $33.2M | Buy |
514,370
+23,411
| +5% | +$1.47M | 0.34% | 58 |
|
|
2014
Q4 | $29M | Sell |
490,959
-8,647
| -2% | -$488K | 0.32% | 63 |
|
|
2014
Q3 | $25.6M | Buy |
499,606
+9,340
| +2% | +$467K | 0.31% | 67 |
|
|
2014
Q2 | $23.8M | Buy |
490,266
+6,928
| +1% | +$341K | 0.29% | 70 |
|
|
2014
Q1 | $25.1M | Buy |
483,338
+6,013
| +1% | +$320K | 0.35% | 60 |
|
|
2013
Q4 | $25.4M | Sell |
477,325
-3,449
| -0.7% | -$176K | 0.37% | 54 |
|
|
2013
Q3 | $22.3M | Buy |
480,774
+19,352
| +4% | +$849K | 0.36% | 54 |
|
|
2013
Q2 | $20.6M | Buy |
+461,422
| New | +$20M | 0.36% | 56 |
|
Other funds holding BMY
Commonwealth Equity Services's BMY Position: Q2 2026 in Review
Commonwealth Equity Services reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $981K and leaving 975,574 shares worth $56.2M. The position accounts for 0.07% of the portfolio, ranked #281.
Commonwealth Equity Services first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $88.8M in Q2 2022. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Commonwealth Equity Services held 975,574 shares of Bristol-Myers Squibb worth $56.2M as of Q2 2026.
- Commonwealth Equity Services sold 17,088 Bristol-Myers Squibb shares in Q2 2026, an estimated $981K.
- Bristol-Myers Squibb made up 0.07% of Commonwealth Equity Services's portfolio in Q2 2026, its #281 holding.
- Commonwealth Equity Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Commonwealth Equity Services's Bristol-Myers Squibb position peaked at $88.8M in Q2 2022.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.